Respiratory Disease Testing Market, By Test Type, By End User, and By Region

Description

Respiratory Disease Testing Market is estimated to be valued at USD 3,495.8 Mn in 2025 and is expected to reach USD 4,600.2 Mn by 2032, growing at a compound annual growth rate (CAGR) of 4% from 2025 to 2032.

Report Coverage		Report Details
Base Year:	2024	Market Size in 2025:	USD 3,495.8 Mn
Historical Data for:	2020 To 2024	Forecast Period:	2025 To 2032
Forecast Period 2025 to 2032 CAGR:	4.00%	2032 Value Projection:	USD 4,600.2 Mn

Respiratory diagnostics are the medical products and technologies that are used to diagnose respiratory diseases and disorders in patients. Respiratory diagnostics is effective as it can diagnose diseases at an early stage. Respiratory disease is a medical condition that affects the structure and organs associated with respiration or breathing. Based on anatomical features, the respiratory system has been segmented into the upper respiratory tract and lower respiratory tract. The upper respiratory tract comprises the pharynx, larynx, and nasal passages, while the lower respiratory tract includes the trachea, lungs, and bronchi. Respiratory disorders, or lung diseases, are disorders such as asthma, cystic fibrosis, emphysema, lung cancer, mesothelioma, pulmonary hypertension, and tuberculosis. If left untreated, lung disease can produce health complications, problematic symptoms, and life-threatening conditions.

Market Dynamics

Development activities such as product launches, approvals, acquisitions, and mergers, among other, are driving the overall market growth. For instance, in November 2021, Cipla Limited, an multinational pharmaceutical company in India, launched Spirofy, India's pneumotach-based portable, wireless Spirometer, on World COPD Day. With this launch, the company intends to revolutionize Obstructive Airway Disease (OAD) diagnosis in India. Such developments are anticipated to contribute to the market growth over the forecast period. For instance, in September 2021, Roche, manufacturing medicines in oncology, immunology, infectious diseases, ophthalmology, and diseases of the central nervous system. Roche which also specializes in in vitro diagnostics and tissue-based cancer diagnostics, launched three molecular polymerase chain reaction (PCR) diagnostic test panels to simultaneously detect and differentiate common respiratory pathogens. Therefore, such advancements in the segment are expected to fuel segment growth.

Key features of the study:

This report provides an in-depth analysis of the global respiratory disease testing market and provides market size (US$ Million) and compound annual growth rate (CAGR) for the forecast period 2025-2032, considering 2024 as the base year
It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
It profiles key players in the global respiratory disease testing market based on the following parameters- company highlights, products portfolio, key highlights, financial performance, and strategies
Key companies covered as a part of this study include CareFusion Corporation, Carestream Health, Inc., COSMED, Futuremed America, Inc., GE Healthcare, MGC Diagnostics Corporation, ndd Medical Technologies, Inc., Nihon Kohden Corporation, Perkin Elmer, Inc., FUJIFILM Healthcare Corporation, Philips Healthcare,Roche Healthcare, Beckton Dickinson and Company, Koninklijke Philips N.V. ResMed Inc., Medtronic, Abbott Diagnostics, and Quest Diagnostics.
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
The global respiratory disease testing market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global respiratory disease testing market

Detailed Segmentation:

Global Respiratory Disease Testing Market, By Test Type:
- Imaging Test
- Spirometry
- Peak Flow Test
- Blood Gas Test
- Lung Volume Test
- Others
Global Respiratory Disease Testing Market, By End User:
- Hospitals
- Physician Offices
- Clinical Laboratories
Global Respiratory Disease Testing Market, By Region:
- North America
- Latin America
- Europe
- Asia Pacific
- Middle East
- Africa
Company Profiles
- CareFusion Corporation
- Carestream Health, Inc.
- COSMED
- Futuremed America, Inc.
- GE Healthcare
- MGC Diagnostics Corporation
- ndd Medical Technologies, Inc.
- Nihon Kohden Corporation
- Perkin Elmer, Inc.
- FUJIFILM Healthcare Corporation
- Philips Healthcare
- Roche Healthcare
- Beckton Dickinson and Company
- Koninklijke Philips N.V.
- ResMed Inc.
- Medtronic
- Abbott Diagnostics
- Quest Diagnostics.

Product Code: CMI4030

1. Research Objectives and Assumptions

Research Objectives
Assumptions
Abbreviations

2. Market Purview

Report Description
- Market Definition and Scope
Executive Summary
- Market Snapshot, By Test Type
- Market Snapshot, By End User
- Market Snapshot, By Region
Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

Market Dynamics
- Drivers
- Restraints
- Market Opportunities
Impact Analysis
Recent Test Launches
Epidemiology
Merger, Acquisition, and Collaboration
Regulatory Scenario
Key Developments
PEST Analysis

4. Global Respiratory disease testing Market- COVID-19 Impact Analysis

Economic Impact
COVID-19 Epidemiology
Impact on Supply and Demand

5. Global Respiratory disease testing Market, By Test Type, 2020-2032, (US$ Mn)

Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021-2032
- Segment Trends
Imaging Test
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Mn)
Spirometry
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Mn)
Peak Flow Test
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Mn)
Blood Gas Test
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Mn)
Lung Volume Test
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Mn)
Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Mn)

6. Global Respiratory disease testing Market, By End User, 2020-2032, (US$ Mn)

Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021-2032
- Segment Trends
Hospitals
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Mn)
Physician Offices
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Mn)
Clinical Laboratories
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Mn)

7. Global Respiratory disease testing Market, By Region, 2020-2032, (US$ Mn)

Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021-2032
North America
- Market Size and Forecast, By Test Type, 2020-2032, (US$ Mn)
- Market Size and Forecast, By End User, 2020-2032, (US$ Mn)
- Market Size and Forecast, By Country, 2020-2032, (US$ Mn)
  - U.S.
  - Canada
Europe
- Market Size and Forecast, By Test Type, 2020-2032, (US$ Mn)
- Market Size and Forecast, By End User, 2020-2032, (US$ Mn)
- Market Size and Forecast, By Country, 2020-2032, (US$ Mn)
  - U.K.
  - Germany
  - Italy
  - France
  - Spain
  - Russia
  - Rest of Europe
Asia Pacific
- Market Size and Forecast, By Test Type, 2020-2032, (US$ Mn)
- Market Size and Forecast, By End User, 2020-2032, (US$ Mn)
- Market Size and Forecast, By Country, 2020-2032, (US$ Mn)
  - China
  - India
  - Japan
  - ASEAN
  - Australia
  - South Korea
  - Rest of Asia Pacific
Latin America
- Market Size and Forecast, By Test Type, 2020-2032, (US$ Mn)
- Market Size and Forecast, By End User, 2020-2032, (US$ Mn)
- Market Size and Forecast, By Country, 2020-2032, (US$ Mn)
  - Brazil
  - Mexico
  - Argentina
  - Rest of Latin America
Middle East
- Market Size and Forecast, By Test Type, 2020-2032, (US$ Mn)
- Market Size and Forecast, By End User, 2020-2032, (US$ Mn)
- Market Size and Forecast, By Country, 2020-2032, (US$ Mn)
  - GCC
  - Israel
  - Rest of Middle East
Africa
- Market Size and Forecast, By Test Type, 2020-2032, (US$ Mn)
- Market Size and Forecast, By End User, 2020-2032, (US$ Mn)
- Market Size and Forecast, By Country/Region, 2020-2032, (US$ Mn)
  - North Africa
  - Central Africa
  - South Africa
  - Rest of Africa

8. Company Profiles

CareFusion Corporation *
- Products Portfolio
- Key Highlights
- Financial Performance
- Strategies
Carestream Health, Inc.
- Products Portfolio
- Key Highlights
- Financial Performance
- Strategies
COSMED
- Products Portfolio
- Key Highlights
- Financial Performance
- Strategies
Futuremed America, Inc.
- Products Portfolio
- Key Highlights
- Financial Performance
- Strategies
GE Healthcare
- Products Portfolio
- Key Highlights
- Financial Performance
- Strategies
MGC Diagnostics Corporation
- Products Portfolio
- Key Highlights
- Financial Performance
- Strategies
ndd Medical Technologies, Inc.
- Products Portfolio
- Key Highlights
- Financial Performance
- Strategies
Nihon Kohden Corporation
- Products Portfolio
- Key Highlights
- Financial Performance
- Strategies
Perkin Elmer, Inc.
- Products Portfolio
- Key Highlights
- Financial Performance
- Strategies
FUJIFILM Healthcare Corporation
- Products Portfolio
- Key Highlights
- Financial Performance
- Strategies
Philips Healthcare
- Products Portfolio
- Key Highlights
- Financial Performance
- Strategies
Roche Healthcare
- Products Portfolio
- Key Highlights
- Financial Performance
- Strategies
Beckton Dickinson and Company
- Products Portfolio
- Key Highlights
- Financial Performance
- Strategies
Koninklijke Philips N.V.
- Products Portfolio
- Key Highlights
- Financial Performance
- Strategies
ResMed Inc.
- Products Portfolio
- Key Highlights
- Financial Performance
- Strategies
Medtronic
- Products Portfolio
- Key Highlights
- Financial Performance
- Strategies
Abbott Diagnostics
- Products Portfolio
- Key Highlights
- Financial Performance
- Strategies
Quest Diagnostics
- Products Portfolio
- Key Highlights
- Financial Performance
- Strategies

9. Section

References
Research Methodology
About us and Sales Contact